A detailed history of Lpl Financial LLC transactions in Caribou Biosciences, Inc. stock. As of the latest transaction made, Lpl Financial LLC holds 10,483 shares of CRBU stock, worth $17,716. This represents 0.0% of its overall portfolio holdings.

Number of Shares
10,483
Holding current value
$17,716
% of portfolio
0.0%

Shares

2 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 08, 2024

BUY
$1.56 - $2.73 $16,353 - $28,618
10,483 New
10,483 $20,000
Q1 2024

May 10, 2024

BUY
$4.82 - $8.26 $115,183 - $197,389
23,897 New
23,897 $122,000

Others Institutions Holding CRBU

About Caribou Biosciences, Inc.


  • Ticker CRBU
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 60,840,800
  • Market Cap $103M
  • Description
  • Caribou Biosciences, Inc., a clinical-stage biopharmaceutical company, engages in the development of genome-edited allogeneic cell therapies for the treatment of hematologic malignancies and solid tumors in the United States and internationally. Its lead product candidates are CB-010, an allogeneic anti-CD19 CAR-T cell therapy that is in phase 1...
More about CRBU
Track This Portfolio

Track Lpl Financial LLC Portfolio

Follow Lpl Financial LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Lpl Financial LLC, based on Form 13F filings with the SEC.

News

Stay updated on Lpl Financial LLC with notifications on news.